#Truvada

PrEP use remains largely limited to white men 25 and older, meaning groups at the very highest risk of HIV are likely not benefiting.

Such generic drugs could save nations huge sums in the coming years.

People with HIV taking Viread, especially if combined with Norvir, should receive regular kidney monitoring.

That’s about to change as two more nonprofit clinics open and provide the HIV prevention pill free of charge.

Following a recent finding of a major drop in HIV diagnoses at the 56 Dean St. clinic, the decline in gonorrhea diagnoses is encouraging.

In a national survey, men who have sex with men also cited anticipated difficulty accessing PrEP as a reason for not taking it.

The Food and Drug Administration recently approved a generic formulation of Gilead Sciences’ antiretroviral Truvada.

The insurer had denied a patient the HIV prevention pill Truvada because of his “High risk homosexual behavior.”

He started HIV treatment immediately, and after sensitive tests showed near-complete loss of virus, he stopped after 34 months.

An analysis of the “on-demand” PrEP study found no new HIV infections among those reporting good adherence and relatively infrequent sex.

Between this study of mixed-HIV-status gay couples and a similar previous study, partners have engaged in about 35,000 condomless sex acts.

Going on PrEP was also linked to a modest increase in STI diagnoses, but the shift was not statistically significant.

If developed commercially, the simple test could help PrEP providers monitor adherence and provide support if necessary.

The science behind Truvada as pre-exposure prophylaxis reveals an awesome tool that is apparently already helping shrink U.S. HIV rates.

If you’re in rural Iowa, you can use TelePrEP to access the HIV prevention pill.